Dyno Therapeutics unveils best-in-class Dyno-bn8 AAV vector for muscle gene therapies, achieving therapeutic delivery with improved safety potential ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In a recent study, his group and ...
TipRanks on MSN
Cytokinetics’ Q3 2025: Progress in Cardiac Therapies
Cytokinetics ( ($CYTK) ) has released its Q3 earnings. Here is a breakdown of the information Cytokinetics presented to its investors.
Lower skeletal muscle mass was associated with an increased risk for short- and long-term mortality in patients with cardiac amyloidosis (CA). This association was particularly strong with ...
Hierarchical structure of muscle and activation of thin filaments. In both skeletal and cardiac muscles under a relaxed state, a low intracellular calcium ion concentration is maintained and the ...
Mayo Clinic researchers have developed a pioneering method to mend damaged hearts without open-heart surgery, an advance that ...
Ohio student athletes could face mandatory cardiac screenings under a bill introduced bipartisan bill introduced in the Ohio ...
Skeletal muscle is the type of muscle that controls movement. Problems with these muscles can be minor, life-threatening, or ongoing problems that make it hard to perform basic daily activities.
Researchers have investigated the effect of increased cell temperature on the contractility of skeletal muscle and cardiac muscle by heating the muscle proteins using advanced microscopical techniques ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results